139 related articles for article (PubMed ID: 26689884)
1. Molecular characterization and functional analysis of pteridine reductase in wild-type and antimony-resistant Leishmania lines.
de Souza Moreira D; Ferreira RF; Murta SM
Exp Parasitol; 2016 Jan; 160():60-6. PubMed ID: 26689884
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony.
Moreira DS; Monte Neto RL; Andrade JM; Santi AM; Reis PG; Frézard F; Murta SM
Int J Parasitol Drugs Drug Resist; 2013 Dec; 3():143-53. PubMed ID: 24533304
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of iron superoxide dismutase-A in wild-type and antimony-resistant Leishmania braziliensis and Leishmania infantum lines.
Tessarollo NG; Andrade JM; Moreira DS; Murta SM
Parasitol Int; 2015 Apr; 64(2):125-9. PubMed ID: 25449290
[TBL] [Abstract][Full Text] [Related]
4. Comparative proteomic analysis of antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum chagasi lines.
Matrangolo FS; Liarte DB; Andrade LC; de Melo MF; Andrade JM; Ferreira RF; Santiago AS; Pirovani CP; Silva-Pereira RA; Murta SM
Mol Biochem Parasitol; 2013 Aug; 190(2):63-75. PubMed ID: 23831370
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of cytosolic tryparedoxin peroxidase in antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum lines.
Andrade JM; Murta SM
Parasit Vectors; 2014 Aug; 7():406. PubMed ID: 25174795
[TBL] [Abstract][Full Text] [Related]
6. Phosphoproteomic analysis of wild-type and antimony-resistant Leishmania braziliensis lines by 2D-DIGE technology.
Moreira Dde S; Pescher P; Laurent C; Lenormand P; Späth GF; Murta SM
Proteomics; 2015 Sep; 15(17):2999-3019. PubMed ID: 25959087
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning, expression and enzymatic assay of pteridine reductase 1 from Iranian lizard Leishmania.
Kazemi B; Tohidi F; Bandehpour M; Yarian F
Iran Biomed J; 2010 Jul; 14(3):97-102. PubMed ID: 21079660
[TBL] [Abstract][Full Text] [Related]
8. Involvement of nucleoside diphosphate kinase b and elongation factor 2 in Leishmania braziliensis antimony resistance phenotype.
Moreira DS; Murta SM
Parasit Vectors; 2016 Dec; 9(1):641. PubMed ID: 27964761
[TBL] [Abstract][Full Text] [Related]
9. Ascorbate peroxidase overexpression protects Leishmania braziliensis against trivalent antimony effects.
Moreira DS; Xavier MV; Murta SMF
Mem Inst Oswaldo Cruz; 2018 Nov; 113(12):e180377. PubMed ID: 30507997
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
Hardy LW; Matthews W; Nare B; Beverley SM
Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081
[TBL] [Abstract][Full Text] [Related]
11. Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species.
Liarte DB; Murta SM
Parasitol Res; 2010 Jun; 107(1):205-12. PubMed ID: 20372925
[TBL] [Abstract][Full Text] [Related]
12. Leishmania infantum induces high phagocytic capacity and intracellular nitric oxide production by human proinflammatory monocyte.
Ribeiro CV; Rocha BFB; Oliveira E; Teixeira-Carvalho A; Martins-Filho OA; Murta SMF; Peruhype-Magalhães V
Mem Inst Oswaldo Cruz; 2020; 115():e190408. PubMed ID: 32321156
[TBL] [Abstract][Full Text] [Related]
13. The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major.
Nare B; Hardy LW; Beverley SM
J Biol Chem; 1997 May; 272(21):13883-91. PubMed ID: 9153248
[TBL] [Abstract][Full Text] [Related]
14. PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major.
Bello AR; Nare B; Freedman D; Hardy L; Beverley SM
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11442-6. PubMed ID: 7972081
[TBL] [Abstract][Full Text] [Related]
15. Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania.
Marquis N; Gourbal B; Rosen BP; Mukhopadhyay R; Ouellette M
Mol Microbiol; 2005 Sep; 57(6):1690-9. PubMed ID: 16135234
[TBL] [Abstract][Full Text] [Related]
16. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity.
Nare B; Luba J; Hardy LW; Beverley S
Parasitology; 1997; 114 Suppl():S101-10. PubMed ID: 9309772
[TBL] [Abstract][Full Text] [Related]
17. A pteridine reductase gene ptr1 contiguous to a P-glycoprotein confers resistance to antifolates in Trypanosoma cruzi.
Robello C; Navarro P; Castanys S; Gamarro F
Mol Biochem Parasitol; 1997 Dec; 90(2):525-35. PubMed ID: 9476799
[TBL] [Abstract][Full Text] [Related]
18. Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy.
Cunningham ML; Beverley SM
Mol Biochem Parasitol; 2001 Apr; 113(2):199-213. PubMed ID: 11295174
[TBL] [Abstract][Full Text] [Related]
19. The role of reduced pterins in resistance to reactive oxygen and nitrogen intermediates in the protozoan parasite Leishmania.
Moreira W; Leblanc E; Ouellette M
Free Radic Biol Med; 2009 Feb; 46(3):367-75. PubMed ID: 19022374
[TBL] [Abstract][Full Text] [Related]
20. Mutant PTR1 proteins from Leishmania tarentolae: comparative kinetic properties and active-site labeling.
Chang CF; Bray T; Whiteley JM
Arch Biochem Biophys; 1999 Aug; 368(1):161-71. PubMed ID: 10415124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
